75 related articles for article (PubMed ID: 9747458)
1. IL-1/IL-3 gene therapy of non-small cell lung cancer (NSCLC) in rats using 'cracked' adenoproducer cells.
Esandi MC; van Someren GD; Bout A; Mulder AH; van Bekkum DW; Valerio D; Noteboom JL
Gene Ther; 1998 Jun; 5(6):778-88. PubMed ID: 9747458
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
[TBL] [Abstract][Full Text] [Related]
3. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
Mikysková R; Indrová M; Símová J; Jandlová T; Bieblová J; Jinoch P; Bubeník J; Vonka V
Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro.
Saeki T; Mhashilkar A; Chada S; Branch C; Roth JA; Ramesh R
Gene Ther; 2000 Dec; 7(23):2051-7. PubMed ID: 11175318
[TBL] [Abstract][Full Text] [Related]
7. Viral and non-viral vectors for cancer gene therapy.
Cristiano RJ
Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin 3 (IL-3) in diagnosis and monitoring of non-small-cell lung cancer].
Mroczko B; Szmitkowski M; Czygier M
Przegl Lek; 1999; 56(12):763-6. PubMed ID: 10789186
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
13. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-3 in gene therapy of cancer.
McBride WH; Dougherty GD; Wallis AE; Economou JS; Chiang CS
Folia Biol (Praha); 1994; 40(1-2):62-73. PubMed ID: 7958065
[TBL] [Abstract][Full Text] [Related]
15. Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.
Geutskens SB; van der Eb MM; Plomp AC; Jonges LE; Cramer SJ; Ensink NG; Kuppen PJ; Hoeben RC
Gene Ther; 2000 Aug; 7(16):1410-6. PubMed ID: 10981668
[TBL] [Abstract][Full Text] [Related]
16. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
Negri DR; Mezzanzanica D; Sacco S; Gadina M; Benigni F; Cajola L; Finocchiaro G; Ghezzi P; Canevari S
Cytokine; 2001 Jul; 15(1):27-38. PubMed ID: 11509006
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line.
Lee JH; Lee CT; Yoo CG; Hong YK; Kim CM; Han SK; Shim YS; Carbone DP; Kim YW
Anticancer Res; 1998; 18(5A):3257-61. PubMed ID: 9858892
[TBL] [Abstract][Full Text] [Related]
18. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
[TBL] [Abstract][Full Text] [Related]
19. Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells.
Ghosh AK; Steele R; Ryerse J; Ray RB
Cancer Res; 2006 Dec; 66(24):11907-12. PubMed ID: 17178888
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC
Gene Ther; 1999 Mar; 6(3):338-49. PubMed ID: 10435084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
